Understanding tumor heterogeneity is crucial because it impacts treatment outcomes. Traditional cancer treatments often target specific cancer cell populations, but due to heterogeneity, other resistant subpopulations can survive, leading to treatment failure and disease recurrence. This is why personalized medicine and targeted therapies are increasingly important in cancer treatment.
